ArticlePLoS neglected tropical diseases2026
Wolbachia prevalence in Aedes aegypti across five comunas of Medellín, Colombia: Implications for post-release surveillance.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A promising sustainable strategy for reducing arbovirus transmission by the mosquito vector Aedes aegypti is the deployment of individuals transinfected with Wolbachia pipientis, a bacterium that inhibits replication of viruses such as dengue and is being used in population replacement programs aimed at blocking Aedes-borne virus transmission. Between 2017 and 2022, the World Mosquito Program released Ae. aegypti infected with the wMel Wolbachia strain throughout Medellín, Colombia. Long-term Wolbachia surveillance following population replacement requires approaches that balance accuracy and cost while providing reliable information regarding infection persistence in targeted populations. Therefore, we assessed current Wolbachia prevalence in Ae. aegypti, surveying five comunas (geographic administrative units) of Medellín spanning ~32.66 km, using ovitrap collections and field sampling of adult mosquitoes and assessed Wolbachia infection using conventional PCR and quantitative PCR (qPCR) in pooled and individual samples. We found that Wolbachia infection remains widespread across the surveyed areas, with estimated infection frequencies ranging from ~60% to near fixation depending on sampling strategy and molecular detection method. Screening pooled adults emerging from ovitraps using conventional PCR provided a cost-effective method for confirming Wolbachia persistence across sites, whereas qPCR of individual field-captured adults provided more sensitive estimates of infection prevalence. Our results suggest that Wolbachia is broadly established in Ae. aegypti populations in the surveyed areas and demonstrate practical approaches for the long-term surveillance of Wolbachia-based vector control programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.